Symbiotic composition for reducing blood lipid and preparation and application of symbiotic composition

Abstract

The invention discloses a symbiotic composition for reducing blood lipid and a preparation and the application of the symbiotic composition. The symbiotic composition for reducing blood lipid comprises prebiotics and probiotics, wherein the weight ratio of the prebiotics to the probiotics is 1-10 to 1-10. By adopting the symbiotic composition disclosed by the invention, physiological bacterial activity of the probiotics can be brought into play, the number of the probiotics can be also selectively and rapidly increased together with the prebiotics, the probiotics are rapid in action speed andlong-lasting in effect, and then the physiological functions of the prebiotics and the probiotics can be brought into play. The symbiotic composition disclosed by the invention is capable of promotingintestinal health, in addition, the probiotics can be rapidly propagated in intestinal tracts under support of corresponding prebiotics, intestinal flora can be regulated, on one hand, the absorptionfunctions of intestinal tracks can be regulated, on the other hand, the content of fat, particularly cholesterol in blood plasma can be reduced. Therefore, the symbiotic composition has a good bloodfat reduction effect.

Description

technical field [0001] The invention belongs to the technical field of microbial additives, and in particular relates to a synbiotic composition for lowering blood fat and its preparation and application. Background technique [0002] Synbiotics, also known as synbiotics or symbiotics, are composite products of probiotics and prebiotics. Probiotics are a class of live microorganisms that are beneficial to the host. Prebiotics refer to a class of food ingredients or substances that can promote the growth of beneficial bacteria. They are probiotic products that are not easily digested by the human body but can selectively stimulate the growth of beneficial bacteria in the intestinal tract or enhance the activity of beneficial bacteria. [0003] In the current technology, there have been related reports on synbiotics, but most of the formulas are unreasonable and cannot achieve better efficacy. What's more, they cannot play a good role in promoting and improving the probiotic ...

AI Technical Summary

Problems solved by technology

[0003] In the current technology, there have been related reports on synbiotics, but most of the formulas are unreasonable and cannot achieve better efficacy. What's more, they cannot play a good role in promoting and improving the probiotics in the body.

Moreover, the existing synbiotic compositions are not highly targeted, and their efficacy is not satisfactory